Tevogen Bio Holdings Inc., incorporated in the Cayman Islands on April 21, 2021, was later merged and reorganized into a Delaware company. Tevogen Bio is a clinical stage professional immunotherapy company that utilizes one of nature's most powerful immune weapons — CD8 + cytotoxic T lymphocytes to develop off-the-shelf, ungenetically modified precision T cell therapies for the treatment of infectious, cancer and neurological diseases, aiming to address the significant unmet needs of a large patient population. 

TVGN

TVGN Profile